VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 35 filers reported holding VINCERX PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,870 | -22.3% | 25,614 | 0.0% | 0.00% | – |
| Q2 2023 | $33,298 | +25.0% | 25,614 | 0.0% | 0.00% | – |
| Q1 2023 | $26,639 | +2.0% | 25,614 | 0.0% | 0.00% | – |
| Q4 2022 | $26,126 | -25.4% | 25,614 | -0.2% | 0.00% | – |
| Q3 2022 | $35,000 | +2.9% | 25,669 | 0.0% | 0.00% | – |
| Q2 2022 | $34,000 | -93.9% | 25,669 | -81.6% | 0.00% | – |
| Q1 2022 | $560,000 | -61.7% | 139,861 | -2.6% | 0.00% | – |
| Q4 2021 | $1,463,000 | -24.8% | 143,530 | +19.2% | 0.00% | – |
| Q3 2021 | $1,946,000 | +133.3% | 120,363 | +87.7% | 0.00% | – |
| Q2 2021 | $834,000 | +140.3% | 64,141 | +256.8% | 0.00% | – |
| Q1 2021 | $347,000 | – | 17,977 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |